Endress+Hauser Raman analyzers equipped with bioprocess probe technology and the BioPAT® Spectro platform by Sartorius provides an ideal interface to high throughput development through single-use commercial manufacturing. Rxn-46 bioprocessing probe technology, adapted to fit Sartorius’ BioPAT® Spectro platform, utilizes the same probe design for Ambr® 15, Ambr®250, and Biostat STR® bioreactors. Choose a bioprocessing probe that meets strict quality standards and helps you scale-up and scale-out.
Benefits
- Integrates with the BioPAT® Spectro platform by Sartorius for high throughput development through single-use manufacturing
- Allows biopharmaceutical companies to more efficiently scale from development to cGMP and offers unparalleled method transfer capabilities
- Delivers non-contact Raman collection for flexible sampling capabilities
2020 Pharma Innovation award winner
The Rxn-46 probe (previously branded Kaiser Raman bIO-PRO, KS) was selected as a 2020 Pharma Innovation Award winner by Pharma Manufacturing Magazine. This probe is an exciting advancement in our already well-established Endress+Hauser Raman bioprocess product portfolio. It provides fast, accurate measurement of key bioprocess variables from lab-to-process, and it is especially well-suited for cell culture research, development, and manufacturing. Click here to learn more.